Skip to main content

Intact MET Immunoassay

BRD ID: 2246
Tier: SOP
Source: DCTD
Document: SOP341203_Intact_METIA.pdf[Size: 388.53 KB]
Number of times downloaded: 860

Description

This document describes quantification of MET levels in lysates of frozen needle tumor biopsies using the Intact MET Immunoassay. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.